CONTACTS 

SUBJECTS
Kaiser Notify UCSF Measurable Disease Observed Examination 070105 IB

2203 -
2203 -    ..
2204 - Summary/Objective
2205 -
220501 - Follow up ref SDS 60 0000. ref SDS 58 0000.
220502 -
220503 -
220504 -
220505 -
220506 -
220508 -  ..
2206 -
2207 -
2208 - Progress
2209 -
220901 - Kaiser Notify UCSF Measurable Disease IBC Spreading
220902 - UCSF Clinical Drug Trial Meeting Schedule Start Treatment
220903 -
220904 - Follow up ref SDS 58 086H, ref SDS 57 086H.
220905 -
220906 - Background on Kaiser collaborating with UCSF on drug trials for Millie
220907 - is reported on 061228. ref SDS 56 086H  On 070101 Millie received
220908 - ref DRP 10 0001 from the primary care physician transmitting language
220909 - from a letter Kaiser received from UCSF that follows up Kaiser's
220910 - letter dated 061229, ref DRP 9 0001, answering questions UCSF
220911 - submitted on qualifying Millie for treatment under clinical studies at
220912 - UCSF, and reviewed in the record on 061230. ref SDS 57 PN5X
220914 -  ..
220915 - UCSF correspondence received on 070101 notified Kaiser that
220916 - "measurable disease" is required for Millie to qualify for clinical
220917 - study of drug trial. ref SDS 58 E23S  On 070105 the doctor recommended
220918 - that Millie approve treatment with the proposed UCSF drug trial
220919 - because it is targeted to treat breast cancer, and IBC, rather than a
220920 - generic cancer treatment, like Navelbine, and Gemzar, which Kaiser
220921 - otherwise has available for Millie's next treatment.  Additionally, at
220922 - that time on 070105, the doctor observed during clinical examination
220923 - that IBC disease has spread from the left to the right breast,
220924 - demonstrating measurable disease.  As a result, Millie asked the
220925 - doctor to notify UCSF the measurable disease was observed.
220927 -  ..
220928 - Millie submitted ref DIT 1 0001 to the primary care physician at
220929 - Kaiser confirming request for Kaiser to notify UCSF of measurable
220930 - disease, and following up the doctor's letter, ref DRP 10 0001, dated
220931 - 061231 and received on 070101. ref SDS 58 519M
220933 -  ..
220934 - Millie's letter says to Kaiser...
220935 -
220936 -    1.  Thanks for submitting the record of our meeting on January 5th.
220937 -        ref DIT 1 0001
220939 -         ..
220940 -    2.  Have you heard from UCSF on Doctor Rugo meeting with me?  I
220941 -        have not been contacted. ref DIT 1 J257
220943 -         ..
220944 -    3.  If we don't hear from Doctor Rugo today, then tomorrow I want
220945 -        Kaiser to send a letter notifying UCSF that examination on
220946 -        January 5, 2007, showed IBC disease is spreading from the left
220947 -        to the right breast; that Kaiser is deferring treatment in
220948 -        order for me to qualify for UCSF drug trials, which offer a
220949 -        better chance of arresting growth of disease "targeted" to
220950 -        breast cancer, and IBC, rather than generic chemotherapy with
220951 -        Navelbine and Gemzar, all as you explained on Friday.
220952 -        ref DIT 1 J25O
220954 -  ..
220955 - Measurable disease case study reported on 070101 shows Millie meets
220956 - this requirement based on best evidence available. ref SDS 58 E23W
220957 -
220958 -            [On 070110 Kasier's letter to UCSF on 070108 and received
220959 -            in the record on 070110 fails to perform scope planned to
220960 -            assist UCSF evaluate measurable disease. ref SDS 61 NN6I
220962 -             ..
220963 -            [On 070116 Millie received consent forms on the Cetuximab
220964 -            and Carboplatin clinical study; UCSF proposes she start
220965 -            treatment on 070124; agreement to this protocol rests on
220966 -            understandings from the meeting at Kaiser on 070105.
220967 -            ref SDS 62 I65I
220969 -  ..
220970 - Millie's letter says to Kaiser continues...
220971 -
220972 -    4.  Please mention I am anxious to start treatment, and would like
220973 -        to know when this will occur. ref DIT 1 J26N
220975 -         ..
220976 -    5.  Please submit a copy to me of your letter to UCSF, and also
220977 -        submit the CA 15-3 test results from 070104. ref DIT 1 J27I
220978 -
220979 -           [On 070110 CA 15-3 56 cancer marker drops dramatically
220980 -           significant improvement aligns with IBC rash intensity
220981 -           subsiding; continuing erratic changes. ref SDS 61 087J
220983 -            ..
220984 -           [On 070116 Jackie called to begin scheduling meeting with
220985 -           Doctor Rugo at UCSF. ref SDS 62 NK8F
220987 -            ..
220988 -           [On 070117 Millie notifies Kaiser that UCSF schedule
220989 -           treatment to start in a week; thanks primary care physician
220990 -           for pushing the case forward. ref SDS 63 638H
220992 -            ..
220993 -           [On 070119 treatment delayed because Kaiser authorization
220994 -           not submitted to UCSF; rescheduled to 070123 or 070124.
220995 -           ref SDS 64 AS5H
220997 -            ..
220998 -           [On 070123 treatment delayed because Kaiser authorization
220999 -           not submitted to UCSF. ref SDS 65 J94O
221001 -            ..
221002 -           [On 071023 CA 15-3 68 rises again to near recent high.
221003 -           ref SDS 65 GK5B
221005 -            ..
221006 -           [On 070123 Millie requests that Kaiser expedite authoriztion
221007 -           for treatment prescribed by doctor, ref SDS 66 YF8U, cites
221008 -           rising CA 15-3 increases urgency to treat advancing disease.
221009 -           ref SDS 65 SX5W
221010 -
221011 -
221012 -
221013 -
221014 -
221015 -
221016 -
221017 -
2211 -

SUBJECTS
Kaiser Reports Progress Schedule Meeting Patient with Doctor UCSF Sc

4503 -
4504 - 1128
450501 -  ..
450502 - Kaiser Asked UCSF About Scheduling Meeting with Millie
450503 -
450504 - Millie received  ref DRT 1 0001 from the primary care physician
450505 - responding to her letter this morning, ref DIT 1 0001, submitted as
450506 - shown above. ref SDS 0 WZ4L
450508 -  ..
450509 - Doctor says to Millie...
450510 -
450511 -        I emailed her yesterday and am awaiting a reply.  She may just
450512 -        contact you directly. ref DRT 1 0001
450513 -
450514 -            [On 070110 Kasier's letter to UCSF on 070108 and received
450515 -            in the record on 070110 fails to perform scope planned to
450516 -            assist UCSF evaluate measurable disease. ref SDS 61 9R3K
450517 -
450518 -
450519 -
450520 -
450521 -
4506 -

SUBJECTS
Patient Requests Kaiser Submit Text of Letter to UCSF on 070109 Requ

7203 -
7204 - 1143
720501 -  ..
720502 - Patient Requests Text of Kaiser's Letter to UCSF and CA 15-3 Results
720503 -
720504 - Millie submitted ref DIT 2 0001 responding to the letter from the
720505 - doctor, ref DIT 2 0001, and received earlier today, per above.
720506 - ref SDS 0 227N
720508 -  ..
720509 - Millie says to the doctor...
720510 -
720511 -    1.  Thanks very much for sending a letter to Doctor Rugo yesterday,
720512 -        as noted in your letter to me this morning, shown below.  When
720513 -        time permits, please submit the text of your letter to UCSF
720514 -        yesterday, so I am aware of communications on my case.
720515 -        ref DIT 2 0001
720517 -  ..
720518 - This implements procedures developed on 061227 for Kaiser to submit
720519 - the record of patient history on communications. ref SDS 55 KO3P
720520 -
720521 -            [On 070110 Kasier's letter to UCSF on 070108 and received
720522 -            in the record on 070110 fails to perform scope planned to
720523 -            assist UCSF evaluate measurable disease. ref SDS 61 9R3K
720525 -  ..
720526 - Millie says to the doctor continues...
720527 -
720528 -    2.  Please further submit results for the CA 15-3 test on 070104,
720529 -        which were not available during the meeting last Friday on
720530 -        070105, but may be posted now. ref DIT 2 1S6G
720532 -  ..
720533 - On 061227 CA 15-7 increased 10 points to 74. ref SDS 55 6P9F
720534 -
720535 -            [On 070110 CA 15-3 56 cancer marker drops dramatically
720536 -            significant improvement aligns with IBC rash intensity
720537 -            subsiding; continuing erratic changes. ref SDS 61 087J
720538 -
720539 -
720540 -
720541 -
720542 -
720543 -
720544 -
720545 -
720546 -
7206 -